Pliant Therapeutics, Inc. (PLRX)
1.155
0.00 (0.00%)
USD |
NASDAQ |
Jun 11, 10:20
Pliant Therapeutics Debt to Equity Ratio : 0.1743 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.1743 |
| December 31, 2025 | 0.1606 |
| September 30, 2025 | 0.2988 |
| June 30, 2025 | 0.2743 |
| March 31, 2025 | 0.234 |
| December 31, 2024 | 0.1979 |
| September 30, 2024 | 0.1741 |
| June 30, 2024 | 0.1534 |
| March 31, 2024 | 0.125 |
| December 31, 2023 | 0.024 |
| September 30, 2023 | 0.024 |
| June 30, 2023 | 0.0273 |
| March 31, 2023 | 0.027 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.0505 |
| September 30, 2022 | 0.0495 |
| June 30, 2022 | 0.1104 |
| March 31, 2022 | 0.0398 |
| December 31, 2021 | 0.0361 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Filana Therapeutics, Inc. | 0.00 |
| CorMedix, Inc. | 0.3315 |
| Eloxx Pharmaceuticals, Inc. | 0.00 |
| Cannabis Global, Inc. | -0.8033 |
| BioStem Technologies, Inc. | 0.1029 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 202.60M |
| Total Liabilities (Quarterly) | 37.43M |
| Shareholders Equity (Quarterly) | 165.17M |
| Current Ratio | 16.89 |
| Net Debt Paydown Yield | 8.05% |